[Current drug therapy in Crohn disease--national guidelines].
Almer
Sven
S
EM-kliniken, Universitetssjukhuset i Linköping. sven.almer@lio.se
Befrits
Ragnar
R
Eriksson
Anders S
AS
Halfvarson
Jonas
J
Hindorf
Ulf
U
Löfberg
Robert
R
D000328:Adult; D000367:Age Factors; D000890:Anti-Infective Agents / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D003424:Crohn Disease / Q000150:complications / Q000175:diagnosis* / Q000601:surgery; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D018529:Nutritional Support; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011788:Quality of Life; D012008:Recurrence; D012074:Remission Induction; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents